{
  "nctId": "NCT03115177",
  "briefTitle": "Can Addition of Doxycycline Perioperatively Reduce Propionibacterium Acnes in Shoulder Arthroplasty?",
  "officialTitle": "Can Addition of Doxycycline Perioperatively Reduce Propionibacterium Acnes in Shoulder Arthroplasty?",
  "protocolDocument": {
    "nctId": "NCT03115177",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2018-05-16",
    "uploadDate": "2018-05-16T21:32",
    "size": 155963,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03115177/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 56,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-11",
    "completionDate": "2017-02",
    "primaryCompletionDate": "2017-02",
    "firstSubmitDate": "2016-04-25",
    "firstPostDate": "2017-04-14"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients undergoing primary total shoulder arthroplasty at Rush University Medical Center\n\nExclusion Criteria:\n\n* Patients with prior shoulder surgery of any kind\n* Patients with a known infection or history of infection with clinical signs such as elevated erythrocyte sedimentation rate, C-reactive protein, positive culture aspiration\n* Patients with a known allergy to doxycycline\n* Patients with a known allergy to cefazolin or penicillin",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "40 Years",
    "maximumAge": "90 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Bacterial Culture",
        "description": "Intraoperative cultures will be taken from all study participants and tested for detection of bacteria. These cultures were held for 14 days and tested for aerobic and anaerobic bacteria. Reported data are presented for the number of participants with a positive bacteria culture from the intraoperative samples.",
        "timeFrame": "2 weeks"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 24,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:29:59.192Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}